Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

MoonLake Immunotherapeutics MLTX

Set alert

Price alert · MLTX

All alert types
11.47 USD -0.31 -2.63%

At close · Nov 2

11.47 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
11.45 × 2
Ask
11.47 × 2
11.17 Day range 12.00
9.46 52-week range 23.29
YTD
-12.97%
1 year
+13.56%
Open
11.80
Prev close
11.78
Mkt cap
976.17M
Vol
972.02K
Avg vol
1.69M
EPS
-3.83
P/E
0.00
Div yield
0.00%
More statistics
Low
11.17
High
12.00
Forward P/E
-3.54
Beta
1.08
Short ratio
4.01
Inst. own
87.73%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
12.60
200-d avg
16.49
1y target
28.54

1D chart

Chart tools
Interval
1m5m15m30m

Signals (27)
NameTimeAgo
RSI: Overbought3:48 PM14 hours ago
MACD: Buy Signal3:42 PM14 hours ago
RSI: Oversold3:31 PM14 hours ago
SMA: Bearish3:22 PM15 hours ago
SMA: Bearish3:21 PM15 hours ago
MACD: Sell Signal3:10 PM15 hours ago
RSI: Overbought3:00 PM15 hours ago
SMA: Bullish2:43 PM15 hours ago
SMA: Bullish2:43 PM15 hours ago
MACD: Buy Signal2:40 PM15 hours ago
RSI: Oversold2:25 PM16 hours ago
MACD: Sell Signal2:20 PM16 hours ago
MACD: Buy Signal1:56 PM16 hours ago
RSI: Oversold1:42 PM16 hours ago
SMA: Bullish1:24 PM17 hours ago
MACD: Sell Signal1:12 PM17 hours ago
RSI: Overbought12:44 PM17 hours ago
MACD: Buy Signal12:37 PM17 hours ago
MACD: Sell Signal12:32 PM17 hours ago
MACD: Buy Signal12:25 PM18 hours ago

Newest 20 of 27.

Analyst view

Consensus: buy

Buy
Price target (mean) 28.54 +148.8% upside
Target (low)
6.00
Target (mean)
28.54
Target (high)
50.00
Ratings (0m) 15 11 buy · 2 hold · 2 sell
  • Strong buy1
  • Buy10
  • Hold2
  • Sell2
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 15
  • 2 months ago 15
  • 3 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MLTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.78081-0.88 – -0.66-1.10+29.0%00.0%7
Next quarter-0.81387-1.01 – -0.67-0.92+11.5%00.0%7
Current year-3.38-3.67 – -2.91-3.53+4.3%00.0%7
Next year-3.33-4.15 – -2.59-3.38+1.6%19.04M0.0%9

Upgrades and downgrades

The latest rating changes

MLTX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 5, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 20, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 1, 2026Leerink PartnersMaintainedOutperformOutperform
Jun 9, 2026BTIGReiteratedBuyBuy
Jun 8, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2026NeedhamMaintainedBuyBuy
May 11, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 30, 2026BTIGReiteratedBuyBuy
Mar 23, 2026Wolfe ResearchUpgradeUnderperformOutperform
Mar 19, 2026Rothschild & CoUpgradeNeutralBuy
Mar 11, 2026Clear StreetMaintainedBuyBuy
Mar 2, 2026RBC CapitalMaintainedSector PerformSector Perform
Mar 2, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 26, 2026NeedhamReiteratedBuyBuy
Feb 24, 2026OppenheimerMaintainedOutperformOutperform
Feb 23, 2026BTIGMaintainedBuyBuy
Feb 23, 2026NeedhamMaintainedBuyBuy
Feb 20, 2026RBC CapitalMaintainedSector PerformSector Perform
Feb 9, 2026BTIGReiteratedBuyBuy
Feb 3, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 15, 2026Goldman SachsDowngradeNeutralSell
Jan 9, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 9, 2026BTIGUpgradeNeutralBuy
Nov 21, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 3, 2025HC Wainwright & Co.UpgradeNeutralBuy
Oct 29, 2025CitigroupDowngradeNeutralSell
Oct 2, 2025HC Wainwright & Co.DowngradeBuyNeutral
Sep 30, 2025GuggenheimMaintainedBuyBuy
Sep 30, 2025WedbushMaintainedOutperformOutperform